Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with APRE: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
APRE
Aprea Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
APRE
Aprea Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
LLY
with
APRE
No shared trading history for LLY and APRE.
Shared co-movers: not yet measured (APRE).
LLY, solid
APRE, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
APRE
Aprea Therapeutics, Inc.
Change
0.48
▼
−4.65%
· post 0.48
Closed
Nov 5 '26
Mkt cap
$7.0M
Revenue
$3,337
Q4 FY25
Revenue
$285,759
FY25
vs
Compare
Closed
Nov 5 '26
LLY
ELI Lilly & Co
vs
APRE
Aprea Therapeutics, Inc.
1,371.32
▼
−3.29%
post 1,363.77
Price
0.48
▼
−4.65%
post 0.48
$1.2T
Mkt cap
$7.0M
Q3 FY26
$24.4B
Revenue
$3,337
Q4 FY25
FY25
$65.2B
Revenue
$285,759
FY25
Change
Change
LLY
1,371.32
▼
−3.29%
vs
APRE
0.48
▼
−4.65%
Closed
Nov 5 '26